46 related articles for article (PubMed ID: 21298348)
1. Role of MMP14 gene polymorphisms in susceptibility and pathological development to hepatocellular carcinoma.
Chen TY; Li YC; Liu YF; Tsai CM; Hsieh YH; Lin CW; Yang SF; Weng CJ
Ann Surg Oncol; 2011 Aug; 18(8):2348-56. PubMed ID: 21298348
[TBL] [Abstract][Full Text] [Related]
2. HNF4α isoforms regulate the circadian balance between carbohydrate and lipid metabolism in the liver.
Deans JR; Deol P; Titova N; Radi SH; Vuong LM; Evans JR; Pan S; Fahrmann J; Yang J; Hammock BD; Fiehn O; Fekry B; Eckel-Mahan K; Sladek FM
Front Endocrinol (Lausanne); 2023; 14():1266527. PubMed ID: 38111711
[TBL] [Abstract][Full Text] [Related]
3. A titratable murine model of progressive emphysema using tracheal porcine pancreatic elastase.
Joshi I; Devine AJ; Joshi R; Smith NJ; Varisco BM
Sci Rep; 2023 Sep; 13(1):15259. PubMed ID: 37709810
[TBL] [Abstract][Full Text] [Related]
4. Study of hsa_circRNA_000121 and hsa_circRNA_004183 in papillary thyroid microcarcinoma.
Bai C; Yang W; Ouyang R; Li Z; Zhang L
Open Life Sci; 2022; 17(1):726-734. PubMed ID: 35891968
[TBL] [Abstract][Full Text] [Related]
5. Target and drug predictions for SARS-CoV-2 infection in hepatocellular carcinoma patients.
Wang L; Ding Y; Zhang C; Chen R
PLoS One; 2022; 17(5):e0269249. PubMed ID: 35639708
[TBL] [Abstract][Full Text] [Related]
6. 24-month decline of non-invasive liver fibrosis markers in HCV-mono and HCV/HIV coinfection after direct-acting antiviral therapy.
Pérez-Is L; Collazos J; de la Fuente B; Morano L; Rivas-Carmenado M; Rodriguez M; Romero-Favela A; Fonseca-González GJ; Melón S; Valle-Garay E; Asensi V
Sci Rep; 2022 Mar; 12(1):3828. PubMed ID: 35264591
[TBL] [Abstract][Full Text] [Related]
7. Gene Polymorphism of MUC15, MMP14, BRAF, and COL1A1 Is Associated with Capsule Formation in Hepatocellular Carcinoma.
Sun W; Zhang Y; Liu B; Duan Y; Li W; Chen J
Can J Gastroenterol Hepatol; 2021; 2021():9990305. PubMed ID: 34007838
[TBL] [Abstract][Full Text] [Related]
8. Genetic Variants of lncRNA
Hsieh MH; Lu HJ; Lin CW; Lee CY; Yang SJ; Wu PH; Chen MK; Yang SF
J Pers Med; 2021 Apr; 11(5):. PubMed ID: 33925911
[TBL] [Abstract][Full Text] [Related]
9. Genetic association of MMP14 promoter variants and their functional significance in gallbladder cancer pathogenesis.
J V; Mishra D; Meher D; Dash S; Besra K; Pattnaik N; Singh SP; Dixit M
J Hum Genet; 2021 Oct; 66(10):947-956. PubMed ID: 33727629
[TBL] [Abstract][Full Text] [Related]
10. Matrix Metallopeptidase 14: A Candidate Prognostic Biomarker for Diffuse Large B-Cell Lymphoma.
Yin C; Zhang J; Shen M; Gu Z; Li Y; Xue W; Shi J; Huang W
Front Oncol; 2020; 10():1520. PubMed ID: 32974187
[TBL] [Abstract][Full Text] [Related]
11. TLR7 Polymorphism (rs179008 and rs179009) in HIV-Infected Individual Naïve to ART.
Singh H; Samani D; Aggarwal S
Mediators Inflamm; 2020; 2020():6702169. PubMed ID: 32565728
[TBL] [Abstract][Full Text] [Related]
12. A DNA aptamer recognizing MMP14 for
Huang X; Zhong J; Ren J; Wen D; Zhao W; Huan Y
Oncol Lett; 2019 Jul; 18(1):265-274. PubMed ID: 31289496
[TBL] [Abstract][Full Text] [Related]
13. Tissue Inhibitor of Metalloproteinase-2 Polymorphisms and Risk for HIV-Associated Neurocognitive Disorder.
Singh H; Jadhav S; Samani D; Nain S
Mediators Inflamm; 2019; 2019():8278095. PubMed ID: 31275061
[TBL] [Abstract][Full Text] [Related]
14. Promoter polymorphism MMP-1 (-1607 2G/1G) and MMP-3 (-1612 5A/6A) in development of HAND and modulation of pathogenesis of HAND.
Singh HO; Marathe SD; Nain S; Samani D; Nema V; Ghate MV; Gangakhedkar RR
J Biosci; 2017 Sep; 42(3):481-490. PubMed ID: 29358561
[TBL] [Abstract][Full Text] [Related]
15. Matrix Metalloproteinases Polymorphisms as Prognostic Biomarkers in Malignant Pleural Mesothelioma.
Štrbac D; Goričar K; Dolžan V; Kovač V
Dis Markers; 2017; 2017():8069529. PubMed ID: 29138529
[TBL] [Abstract][Full Text] [Related]
16. Matrix metalloproteases and their tissue inhibitors in non-alcoholic liver fibrosis of human immunodeficiency virus-infected patients.
Collazos J; Valle-Garay E; Suárez-Zarracina T; Montes AH; Cartón JA; Asensi V
World J Virol; 2017 May; 6(2):36-45. PubMed ID: 28573088
[TBL] [Abstract][Full Text] [Related]
17. Paracrine regulation of matrix metalloproteinases contributes to cancer cell invasion by hepatocellular carcinoma-secreted 14-3-3σ.
Liu CC; Chang TC; Lin YT; Yu YL; Ko BS; Sung LY; Liou JY
Oncotarget; 2016 Jun; 7(24):36988-36999. PubMed ID: 27175590
[TBL] [Abstract][Full Text] [Related]
18. In-depth analysis of secretome and N-glycosecretome of human hepatocellular carcinoma metastatic cell lines shed light on metastasis correlated proteins.
Li X; Jiang J; Zhao X; Zhao Y; Cao Q; Zhao Q; Han H; Wang J; Yu Z; Peng B; Ying W; Qian X
Oncotarget; 2016 Apr; 7(16):22031-49. PubMed ID: 27014972
[TBL] [Abstract][Full Text] [Related]
19. Membrane type 1-matrix metalloproteinase induces epithelial-to-mesenchymal transition in esophageal squamous cell carcinoma: Observations from clinical and in vitro analyses.
Pang L; Li Q; Li S; He J; Cao W; Lan J; Sun B; Zou H; Wang C; Liu R; Wei C; Wei Y; Qi Y; Hu J; Liang W; Zhang WJ; Wan M; Li F
Sci Rep; 2016 Feb; 6():22179. PubMed ID: 26916665
[TBL] [Abstract][Full Text] [Related]
20. Diosmetin inhibits the metastasis of hepatocellular carcinoma cells by downregulating the expression levels of MMP-2 and MMP-9.
Liu J; Wen X; Liu B; Zhang Q; Zhang J; Miao H; Zhu R
Mol Med Rep; 2016 Mar; 13(3):2401-8. PubMed ID: 26847170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
